Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 17 results:
Author Title Type [ Year] Filters: Author is Kloszewska, Iwona [Clear All Filters]
Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer's Disease..
J Alzheimers Dis. 60(3), 809-817.
(2017). Association of blood lipids with Alzheimer's disease: A comprehensive lipidomics analysis..
Alzheimers Dement. 13(2), 140-151.
(2017). A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease..
J Alzheimers Dis. 56(3), 1159-1174.
(2017). Novel genetic loci associated with hippocampal volume..
Nat Commun. 8, 13624.
(2017). Disrupted Network Topology in Patients with Stable and Progressive Mild Cognitive Impairment and Alzheimer's Disease..
Cereb Cortex. 26(8), 3476-3493.
(2016). The effect of increased genetic risk for Alzheimer's disease on hippocampal and amygdala volume..
Neurobiol Aging. 40, 68-77.
(2016). Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease..
Neurobiol Aging. 35(2), 271-8.
(2014). Different multivariate techniques for automated classification of MRI data in Alzheimer's disease and mild cognitive impairment..
Psychiatry Res. 212(2), 89-98.
(2013). Inflammatory proteins in plasma are associated with severity of Alzheimer's disease..
PLoS One. 8(6), e64971.
(2013). Alzheimer's disease and age-related macular degeneration have different genetic models for complement gene variation..
Neurobiol Aging. 33(8), 1843.e9-17.
(2012). Tocopherols and tocotrienols plasma levels are associated with cognitive impairment..
Neurobiol Aging. 33(10), 2282-90.
(2012). Automated hippocampal shape analysis predicts the onset of dementia in mild cognitive impairment..
Neuroimage. 56(1), 212-9.
(2011). Combinatorial markers of mild cognitive impairment conversion to Alzheimer's disease--cytokines and MRI measures together predict disease progression..
J Alzheimers Dis. 26 Suppl 3, 395-405.
(2011). Deep sequencing of the Nicastrin gene in pooled DNA, the identification of genetic variants that affect risk of Alzheimer's disease..
PLoS One. 6(2), e17298.
(2011). Plasma biomarkers of brain atrophy in Alzheimer's disease..
PLoS One. 6(12), e28527.
(2011). Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease..
Arch Gen Psychiatry. 67(7), 739-48.
(2010). AddNeuroMed--the European collaboration for the discovery of novel biomarkers for Alzheimer's disease..
Ann N Y Acad Sci. 1180, 36-46.
(2009).